keyword
https://read.qxmd.com/read/38232245/new-cardiovascular-biomarkers-in-breast-cancer-patients-undergoing-doxorubicin-based-chemotherapy
#1
JOURNAL ARTICLE
Rodrigo Mendonça Cardoso Pestana, Júnea Paolucci Paiva Silvino, Angélica Navarro de Oliveira, Cintia Esteves Soares, Adriano de Paula Sabino, Ricardo Simões, Karina Braga Gomes
BACKGROUND: Central Illustration : New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy. Cardiovascular diseases (CVDs) are relevant to the management of breast cancer treatment since a substantial number of patients develop these complications after chemotherapy. OBJECTIVE: This study aims to evaluate new cardiovascular biomarkers, namely CXCL-16 (C-X-C motif ligand 16), FABP3 (fatty acid binding protein 3), FABP4 (fatty acid binding protein 4), LIGHT (tumor necrosis factor superfamily member 14/TNFS14), GDF-15 (Growth/differentiation factor 15), sCD4 (soluble form of CD14), and ucMGP (uncarboxylated Matrix Gla-Protein) in breast cancer patients treated with doxorubicin (DOXO)...
December 2023: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/34991833/the-prognostic-role-of-baseline-18-f-fdg-pet-ct-suvmax-and-suvmax-change-in-patients-with-node-positive-breast-cancer-receiving-neoadjuvant-chemotherapy
#2
JOURNAL ARTICLE
Canan Can, Nadiye Akdeniz, Halil Kömek, Cihan Gündoğan, Zuhat Urakçı, Abdurrahman Işıkdoğan
OBJECTIVE: This study aimed to determine the prognostic role of baseline maximum standardized uptake value (SUVmax) obtained by pretreatment PET/CT and the change in SUVmax (ΔSUVmax [%]) in patients with axillary lymph node-positive breast cancer receiving neoadjuvant chemotherapy (NAC). METHODS: One hundred and eighty patients with baseline SUVmax and 121 patients with SUVmax measurement after treatment were evaluated in the study. The baseline SUVmax value of the breast (SUVmaxB I) and axilla (SUVmaxA I) and the change in the SUVmax of the breast (ΔSUVmaxB ) and axilla (ΔSUVmaxA ) were measured...
January 2022: Revista española de medicina nuclear e imagen molecular
https://read.qxmd.com/read/34663545/neoplastic-meningitis-in-solid-tumours-updated-review-of-diagnosis-prognosis-therapeutic-management-and-future-directions
#3
REVIEW
E García Molina, M Penas-Prado
Neoplastic meningitis (NM) is a relatively frequent metastatic complication of cancer associated with high levels of neurological morbidity and generally poor prognosis. It appears in 5%-15% of patients with solid tumours, the most frequent being breast and lung cancer and melanoma. Symptoms are caused by involvement of the cerebral hemispheres, cranial nerves, spinal cord, and nerve roots, and are often multifocal or present with signs and symptoms of intracranial hypertension. The main diagnostic tools are the neurological examination, brain and spinal cord contrast-enhanced magnetic resonance imaging, and cerebrospinal fluid analysis including cytology, although studies have recently been conducted into the detection of tumour cells and DNA in the cerebrospinal fluid, which increases diagnostic sensitivity...
2022: Neurología
https://read.qxmd.com/read/34353770/the-prognostic-role-of-baseline-18-f-fdg-pet-ct-suvmax-and-suvmax-change-in-patients-with-node-positive-breast-cancer-receiving-neoadjuvant-chemotherapy
#4
JOURNAL ARTICLE
C Can, N Akdeniz, H Kömek, C Gündoğan, Z Urakçı, A Işıkdoğan
OBJECTIVE: This study aimed to determine the prognostic role of baseline maximum standardized uptake value (SUVmax) obtained by pretreatment PET/CT and the change in SUVmax (ΔSUVmax [%]) in patients with axillary lymph node-positive breast cancer receiving neoadjuvant chemotherapy (NAC). METHODS: One hundred and eighty patients with baseline SUVmax and 121 patients with SUVmax measurement after treatment were evaluated in the study. The baseline SUVmax value of the breast (SUVmaxB I) and axilla (SUVmaxA I) and the change in the SUVmax of the breast (ΔSUVmaxB ) and axilla (ΔSUVmaxA) were measured...
August 2, 2021: Revista Española de Medicina Nuclear e Imagen Molecular
https://read.qxmd.com/read/33863696/radioguided-surgery-with-iodine-125-seeds-in-breast-cancer-patients-treated-with-neoadjuvant-chemotherapy
#5
JOURNAL ARTICLE
A C Rebollo Aguirre, J Fernández Fernández, R Sánchez Sánchez, I Mendoza Arnau, D J Rivas Navas, S Martínez Meca
OBJECTIVE: To evaluate the use of radioactive iodine-125 seed (RIS) in breast and/or axillary surgery, in patients with breast cancer treated with neoadjuvant chemotherapy (NAC). MATERIAL AND METHODS: Prospective study between January 2016 and June 2020. 80 women T1-3,N0-2,M0: 30 RIS marking the breast tumor, 36 both the tumor and the biopsied positive axillary node, and 14 only the axilla. Age: 54.7±11.4 years. Tumor size: 34.1±14.6mm. Histological type: invasive ductal carcinoma 90...
April 13, 2021: Revista española de medicina nuclear e imagen molecular
https://read.qxmd.com/read/33612313/health-care-costs-of-breast-prostate-colorectal-and-lung-cancer-care-by-clinical-stage-and-cost-component
#6
JOURNAL ARTICLE
Oliver Ibarrondo, Garbiñe Lizeaga, José Miguel Martínez-Llorente, Igor Larrañaga, Myriam Soto-Gordoa, Isabel Álvarez-López
OBJECTIVE: To measure 3-year care costs of breast, prostate, colorectal and lung cancers disaggregated by site and clinical stage. METHOD: A retrospective observational design was employed to investigate care costs of cases recorded in the Registry of the Basque Country between 2010 and 2015. Data gathered included TNM stage and demographic, clinical and resource use variables. Total costs per patient with stage IV disease were calculated by combining generalized linear models with parametric survival analysis...
February 18, 2021: Gaceta Sanitaria
https://read.qxmd.com/read/33191151/mri-guided-roll-snoll-in-breast-cancer-patients-treated-with-neoadjuvant-chemotherapy
#7
JOURNAL ARTICLE
G Hernández-Cortés, S Fuertes, V Martínez, M Rubio, U Vera, R Murillo, L González-Cortijo, E Del Cerro, R Mohedano, R Sainz de la Cuesta
PURPOSE: To describe the results of MRI (magnetic resonance image) guided ROLL (radioguided occult lesion localization) and SNOLL (sentinel node occult lesion localization) in the localization of residual disease after neoadjuvant chemotherapy for breast cancer, as well as assessing the surgical results obtained and disease free survival. METHODS: Prospective observational analysis of 132 patients with 136 tumors, treated with neoadjuvant chemotherapy at our hospital between 2011-2017...
March 2021: Revista española de medicina nuclear e imagen molecular
https://read.qxmd.com/read/20963362/prognosis-for-patients-diagnosed-with-pregnancy-associated-breast-cancer-a-paired-case-control-study
#8
COMPARATIVE STUDY
Wagner Brant Moreira, Eduardo Carvalho Brandão, Aleida Nazareth Soares, Clécio Enio Murta de Lucena, Carlos Maurício Figueiredo Antunes
CONTEXT AND OBJECTIVE: Previous studies have suggested that the occurrence of pregnancy concomitantly with a diagnosis of breast cancer may affect the evolution of the neoplasia. The present study aimed to compare pregnancy-associated breast cancer (PABC) patients with non-pregnant cancer patients (controls) in relation to the time taken to diagnose the disease, tumor characteristics and mortality. DESIGN AND SETTING: A retrospective, paired case-control study was conducted at the Hospital da Santa Casa de Misericórdia and Centro de Quimioterapia Antiblástica e Imunoterapia in Belo Horizonte, Brazil...
May 2010: São Paulo Medical Journal
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.